Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022

IntroductionDespite significant advances in multiple sclerosis (MS) treatment, a substantial proportion of people with MS (pwMS) remains untreated with disease-modifying therapies (DMTs). This study aimed to assess the proportion of DMT-untreated pwMS according to clinical and sociodemographic chara...

Full description

Saved in:
Bibliographic Details
Main Authors: Ann-Sophie Stratil, Steffeni Papukchieva, Nils-Henning Neß, Inge Wolf, Antonios Bayas, Peter Flachenecker, Benjamin Friedrich
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Neurology
Subjects:
multiple sclerosis
real-world data
healthcare utilization
disease modifying therapy-untreated
regionality
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1561810/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2025.1561810/full

Similar Items